The gout medication colchicine will be tested in a large UK study looking into potential early-stage Covid-19 treatments and enrollment criteria was widened for the latest arm of the trial, University of Oxford researchers said on March 3.

The American Lung Association announced a $25 million initiative to support the fight against COVID-19, as well as future viral pandemics.